drugset / Trial / NCT00432484

Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis

NCT00432484

Phase 2 Completed 70 enrolled Chinese University of Hong Kong
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To study the efficacy of TCM as an effective supplement in addition to the traditional treatment in RA.

Timeline

Start
2005-05
Primary completion
2006-12
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cotex phellodendri Unknown 2.4 g Oral
Comparator LingZhi Traditional medicine (herbal / TCM) 4 g Oral
Comparator Radix achyranthes Bidentatae Unknown 2.4 g Oral
Comparator Rhizoma atractylodis Unknown 2.4 g Oral

Indications